Abstract:Background Investigations on radiation‐induced lung injury (RILI) have predominantly focused on local effects, primarily those associated with radiation damage to lung parenchyma. However, recent studies from our group and others have revealed that radiation‐induced damage to branching serial structures such as airways and vessels may also have a substantial impact on post‐radiotherapy (RT) lung function. Furthermore, recent results from multiple functional lung avoidance RT trials, although promising, have demonstrated only modest toxicity reduction, likely because they were primarily focused on dose avoidance to lung parenchyma. These observations emphasize the critical need for predictive dose‐response models that effectively incorporate both local and distant RILI effects. Purpose We develop and validate a predictive model for ventilation loss after lung RT. This model, referred to as P+A, integrates local (parenchyma [P]) and distant (central and peripheral airways [A]) radiation‐induced damage, modeling partial (narrowing) and complete (collapse) obstruction of airways. Methods In an IRB‐approved prospective study, pre‐RT breath‐hold CTs (BHCTs) and pre‐ and one‐year post‐RT 4DCTs were acquired from lung cancer patients treated with definitive RT. Up to 13 generations of airways were automatically segmented on the BHCTs using a research virtual bronchoscopy software. Ventilation maps derived from the 4DCT scans were utilized to quantify pre‐ and post‐RT ventilation, serving, respectively, as input data and reference standard (RS) in model validation. To predict ventilation loss solely due to parenchymal damage (referred to as P model), we used a normal tissue complication probability (NTCP) model. Our model used this NTCP‐based estimate and predicted additional loss due radiation‐induced partial or complete occlusion of individual airways, applying fluid dynamics principles and a refined version of our previously developed airway radiosensitivity model. Predictions of post‐RT ventilation were estimated in the sublobar volumes (SLVs) connected to the terminal airways. To validate the model, we conducted a k‐fold cross‐validation. Model parameters were optimized as the values that provided the lowest root mean square error (RMSE) between predicted post‐RT ventilation and the RS for all SLVs in the training data. The performance of the P+A and the P models was evaluated by comparing their respective post‐RT ventilation values with the RS predictions. Additional evaluation using various receiver operating characteristic (ROC) metrics was also performed. Results We extracted a dataset of 560 SLVs from four enrolled patients. Our results demonstrated that the P+A model consistently outperformed the P model, exhibiting RMSEs that were nearly half as low across all patients (13 ± 3 percentile for the P+A model vs. 24 ± 3 percentile for the P model on average). Notably, the P+A model aligned closely with the RS in ventilation loss distributions per lobe, particularly in regions exposed to doses ≥13.5 Gy. The ROC analysis further supported the superior performance of the P+A model compared to the P model in sensitivity (0.98 vs. 0.07), accuracy (0.87 vs. 0.25), and balanced predictions. Conclusions These early findings indicate that airway damage is a crucial factor in RILI that should be included in dose‐response modeling to enhance predictions of post‐RT lung function.

Are Lung Ntcp Models Different in Hypofractionated and Standard Fractionated Radiotherapy?

Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis

Optimal Radiotherapy Fractionation Regimens for Early-Stage Non-Small-Cell Lung Cancer

Dosimetric Comparison of IMPT Vs VMAT for Multiple Lung Lesions: an NTCP Model-Based Decision-Making Strategy

Comparison of Radiobiological Models for Evaluation of Radiotherapy Treatment Planning of Breast Cancer

Effect of Normal Lung Definition on Lung Dosimetry and Lung Toxicity Prediction in Radiation Therapy Treatment Planning

Dosimetric Factors and Lyman Normal-Tissue Complication Modelling Analysis for Predicting Radiation-Induced Lung Injury in Postoperative Breast Cancer Radiotherapy: a Prospective Study

Is it necessary to prescribe the same dose to subclinical lesions as gross tumor volume in non-small-cell lung cancer? —a failure pattern analysis

The potential of integrating stereotactic ablative radiotherapy techniques with hyperfractionation for lung cancer

Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy

A novel predictor for dosimetry data of lung and the radiation pneumonitis incidence prior to SBRT in lung cancer patients

Intensity-modulated Proton and Carbon-Ion Radiotherapy Using a Fixed-Beam System for Locally Advanced Lung Cancer: Dosimetric Comparison with X-Ray Radiotherapy and Normal Tissue Complication Probability (NTCP) Evaluation.

Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical Trial

Estimation of the Effect of Target and Normal Tissue Sparing Based on Equivalent Uniform Dose-Based Optimization in Hypofractionated Radiotherapy for Lung Cancer

Integrating local and distant radiation‐induced lung injury: Development and validation of a predictive model for ventilation loss

Developing a prediction model for radiation pneumonitis in lung cancer patients treated with stereotactic body radiation therapy combined with clinical, dosimetric factors and laboratory biomarkers

Functional Dosimetric Metrics During the Mid-Course of Radiation Therapy May Predict Radiation-Induced Lung Toxicity Better in Patients with Non-Small Cell Lung Cancer

Development and Validation of a Random Forest Model for Predicting Radiation Pneumonitis in Lung Cancer Patients Receiving Moderately Hypofractionated Radiotherapy: a Retrospective Cohort Study

Modeling of the resensitization effect on carbon-ion radiotherapy for stage I non-small cell lung cancer

Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group

NTCP Modeling of Hypothyroidism after Supraclavicular-Directed Radiation Therapy for Breast Cancer